The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene; Novartis
Consulting or Advisory Role - Celgene; Novartis; Roche
Speakers' Bureau - Celgene; Novartis
 
Consulting or Advisory Role - Celgene (Inst); Janssen (Inst); Takeda (Inst)
Research Funding - Celgene (Inst); Janssen (Inst); Takeda (Inst)
Fedratinib (FEDR) in myelofibrosis (MF) patients previously treated with ruxolitinib (RUX): A reanalysis of the JAKARTA-2 study.
 
Claire N. Harrison
Honoraria - Celgene; CTI BioPharma Corp; Gilead Sciences; Novartis; Shire
Speakers' Bureau - CTI BioPharma Corp; Gilead Sciences; Incyte; Novartis; Shire
Research Funding - Celgene (Inst); Novartis (Inst)
 
Nicolaas Schaap
Consulting or Advisory Role - Celgene (Inst); Novartis (Inst)
 
Alessandro M Vannucchi
Consulting or Advisory Role - Celgene; Incyte; Novartis
Speakers' Bureau - Novartis; Shire
 
Jean-Jacques Kiladjian
Honoraria - Novartis; Shire
Consulting or Advisory Role - Incyte; Novartis; Shire
Research Funding - AOP Orphan Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Incyte; Novartis; Shire
 
Eric Jourdan
Consulting or Advisory Role - Novartis
 
Richard T. Silver
Speakers' Bureau - PharmaEssentia
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; PharmaEssentia
 
Harry C. Schouten
Honoraria - Alexion Pharmaceuticals; Gilead Sciences; Novartis; Sanofi
Travel, Accommodations, Expenses - Alexion Pharmaceuticals
 
Francesco Passamonti
No Relationships to Disclose
 
Sonja Zweegman
No Relationships to Disclose
 
Moshe Talpaz
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene
Research Funding - Asana Biosciences; Constellation Pharmaceuticals; CTI BioPharma Corp; Gilead Sciences; Incyte; Janssen; Novartis; NS Pharma; Promedior; Samus; Stemline Therapeutics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Srdan Verstovsek
Consulting or Advisory Role - Celgene; Constellation Pharmaceuticals; Incyte; Novartis; Pragmatist; Sierra Oncology
Research Funding - Blueprint Medicines; Celgene; CTI BioPharma Corp; Genentech; Gilead Sciences; Incyte; Novartis; NS Pharma; Promedior; Roche
 
Torsten Gerike
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Shelonitda Rose
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Mingyu Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Carrie Brownstein
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Ruben A. Mesa
Honoraria - AOP Orphan Pharmaceuticals; Novartis; shire
Consulting or Advisory Role - Baxalta; Galena Biopharma; Incyte; Novartis
Research Funding - Celgene (Inst); CTI (Inst); Genentech (Inst); Gilead Sciences (Inst); Incyte (Inst); NS Pharma (Inst); Pfizer (Inst); Pharmaessentia (Inst); Promedior (Inst)
Travel, Accommodations, Expenses - AOP Orphan Pharmaceuticals; Incyte; Novartis